Lewis B. Silverman, MD

Pediatric Hematology-Oncology
Accepting New Patients
Treats Children
Virtual Visits/Telehealth
Profile Headshot

Overview

Dr. Lewis Silverman is the Director of Pediatric Hematology/Oncology/Stem Cell Transplantation and Professor of Pediatrics practicing at Columbia University Irving Medical Center. Dr. Silverman is a graduate of Harvard University (AB, Biology) and Harvard Medical School. He completed his pediatric residency at Boston Children's Hospital and fellowship in pediatric hematology and oncology at Boston Children's Hospital and the Dana-Farber Cancer Institute. He is board-certified in Pediatric Hematology/Oncology. His professional interests focus on the care of children with pediatric leukemia, especially those with acute lymphoblastic leukemia (ALL).

Academic Appointments

  • Professor of Pediatrics at CUMC

Administrative Titles

  • Director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Stem Cell Transplantation
  • Associate Director for Pediatric Cancers, HICCC

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

161 Fort Washington Avenue
New York, NY 10032
Phone:

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • PPO
  • Student Health

Affinity Health Plan

  • Medicaid Managed Care

Amerigroup of New Jersey

  • New Jersey Services (Medicaid Managed Care)

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Harvard Medical School
  • Residency: Boston Children's Hospital
  • Fellowship: Boston Children's Hospital

Board Certifications

  • Pediatric Hematology-Oncology

Research

For over 20 years, Dr. Silverman has led the DFCI ALL Consortium, which conducts PI-initiated, multi-institutional clinical trials in children and adolescents with acute lymphoblastic leukemia; he also holds several leadership roles in the Children's Oncology Group, the NCI-sponsored clinical trials cooperative group for pediatric cancer. In addition, he currently serves on the NCI Pediatric Leukemia and Lymphoma Steering Committee, which evaluates and prioritizes concepts for trials in pediatric hematologic malignancies to be conducted by the NCI’s NCTN cooperative groups, and has been a long-standing Editorial Board member of the NCI Pediatric Oncology PDQ website, which provides comprehensive, evidence-based cancer summaries for health-care professionals. He has published over 160 peer-reviewed articles in journals including Blood, Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology and the New England Journal of Medicine.